Abstract Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many
human disorders. The persistence of these viral genomes in all malignant cells, yet with the …

The close association of Epstein–Barr virus (EBV) infection with non‐keratinizing
nasopharyngeal carcinomas and a subset of gastric carcinomas suggests that EBV infection …

Epstein-Barr virus (EBV) encodes genes that ensure its persistence in human B
lymphocytes. Some of the genes encourage B-cell proliferation; others are poised to evade …

We show clear evidence for direct infection of various human epithelial cells by Epstein-Barr
virus (EBV) in vitro. The successful infection was achieved by using recombinant EBV (Akata …

Previous studies on Epstein-Barr virus (EBV)-positive B-cell lines have identified two distinct
forms of virus latency. Lymphoblastoid cell lines generated by virus-induced transformation …

Epstein-Barr virus (EBV), a human γ-herpesvirus, can establish both nonproductive (latent)
and productive (lytic) infections. Although the CD8+ cytotoxic T lymphocyte (CTL) response …

Nitric oxide (NO) produced by murine macrophages is important in murine resistance to
ectromelia virus, herpes simplex virus, and vaccinia virus infection. In contrast, NO …

Epstein–Barr virus (EBV) is associated with a still growing spectrum of clinical disorders,
ranging from acute and chronic inflammatory diseases to lymphoid and epithelial …

The Epstein–Barr virus (EBV) latent membrane protein 2A (LMP2A) blocks B-cell receptor
(BCR) signal transduction in EBV-immortalized B lymphocytesin vitro. The cytoplasmic …

The role of latent membrane protein 2 (LMP2) in Epstein-Barr virus (EBV) infection was
evaluated by using latently infected primary B lymphocytes that had been growth …